Chiron Real Estate grants COO 23,855 stock options

Rhea-AI Filing Summary

Chiron Real Estate Inc. (XRN) reported that COO Roseth Aaron Robert received a grant of options to buy 23,855 shares of common stock at an exercise price of $60.00 per share, expiring on August 27, 2036. The options vest in three equal annual installments on August 27, 2027, 2028, and 2029, subject to his continued service. The grant was made as an employment inducement award outside the company’s 2016 Equity Incentive Plan under NYSE Listing Rule 303A.08, approved by the Compensation Committee consisting solely of independent directors. The filing also clarifies that Roseth was previously misidentified as a director and is correctly reported as an officer (COO).

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Roseth Aaron Robert

Role COO

Type	Security	Shares	Price	Value
Grant/Award	Option (Right to buy) F1, F2	23,855	$0.00	$0.00

Holdings After Transaction: Option (Right to buy) — 23,855 shares (Direct)

Footnotes (2)

1. F1. The options have an exercise price of $60.00 per share and the shares subject to the options become exercisable in three equal annual installments on each of August 27, 2027, August 27, 2028 and August 27, 2029, subject to the Reporting Person's continued service through each applicable vesting date.
2. F2. The options were granted outside of the Issuer's 2016 Equity Incentive Plan as an employment inducement award under New York Stock Exchange Listing Rule 303A.08 and as a material inducement to the Reporting Person entering into employment with the Issuer. The awards were approved by the Compensation Committee of the Board of Directors, consisting solely of independent directors, in reliance on the employment inducement exemption under NYSE Listing Rule 303A.08.

Key Figures

Options Granted: 23,855 options Exercise Price: $60.00 per share Expiration Date: 2036-08-27 +2 more

5 metrics

Options Granted 23,855 options Grant of options to COO on 2026-08-27

Exercise Price $60.00 per share Exercise price of COO option grant

Expiration Date 2036-08-27 Option grant expiration date

Vesting Installments 3 installments Three equal annual vesting dates in 2027, 2028, 2029

Underlying Common Stock 23,855 shares Shares of common stock underlying the options

Key Terms

employment inducement award, New York Stock Exchange Listing Rule 303A.08, Equity Incentive Plan, independent directors

4 terms

employment inducement award financial

"The options were granted ... as an employment inducement award under New York..."

An employment inducement award is a grant of company stock, options, or other equity given to a new hire as a joining bonus to encourage them to work for the company. Like a signing bonus in cash, it ties the employee’s pay to the company’s future value and often vests over time. Investors care because these awards increase outstanding shares and compensation costs, affecting per‑share value and motivating executives to meet performance goals.

New York Stock Exchange Listing Rule 303A.08 regulatory

"…under New York Stock Exchange Listing Rule 303A.08 and as a material inducement…"

Equity Incentive Plan financial

"The options were granted outside of the Issuer's 2016 Equity Incentive Plan…"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

independent directors regulatory

"…approved by the Compensation Committee of the Board of Directors, consisting solely of independent..."

Members of a company’s board who do not have significant business, family, or financial ties to the company and are not part of its management; they are chosen to provide impartial oversight of strategy, financial reporting, executive pay and risk. They matter to investors because independent directors act like an objective referee, helping ensure decisions favor shareholders’ long-term interests rather than insiders, which can strengthen trust and reduce the chance of mismanagement or conflicts of interest.

FAQ

What equity award did COO Roseth Aaron Robert receive from Chiron Real Estate Inc. (XRN)?

COO Roseth Aaron Robert received an option grant for 23,855 shares of Chiron Real Estate Inc. common stock with an exercise price of $60.00 per share, expiring on August 27, 2036. The award is structured as an employment inducement grant.

What are the vesting terms of the new stock options reported for XRN’s COO?

The options vest in three equal annual installments on August 27, 2027, August 27, 2028, and August 27, 2029, and each installment is subject to the COO’s continued service with Chiron Real Estate Inc. through the applicable vesting date.

What is the exercise price and expiration date of the COO’s options at Chiron Real Estate Inc. (XRN)?

The options have an exercise price of $60.00 per share and an expiration date of August 27, 2036, giving the COO the right to purchase shares at that price if and when the options become exercisable.

Was the option grant to XRN’s COO made under Chiron Real Estate Inc.’s 2016 Equity Incentive Plan?

No. The options were granted outside Chiron Real Estate Inc.’s 2016 Equity Incentive Plan as an employment inducement award under New York Stock Exchange Listing Rule 303A.08, and were approved by the Compensation Committee of the Board of Directors.

Did the Form 4 clarify Roseth Aaron Robert’s role at Chiron Real Estate Inc. (XRN)?

Yes. The filing states he was previously inadvertently designated as a director in an earlier Form 4. It clarifies that he was not a director at that time and that this Form 4 correctly reflects his status as an officer (COO).

Were the XRN COO’s option transactions reported under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not marked, and there is no footnote indicating that this option grant was made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/31/2026 - 07:26 PM Accepted by SEC EDGAR 08/31/2026 - 07:25 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Roseth Aaron Robert

(Last) (First) (Middle)

7373 WISCONSIN AVENUE, SUITE 800

(Street)

BETHESDA MARYLAND 20814

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Chiron Real Estate Inc. [ XRN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to buy)	$60	08/27/2026		A		23,855		(1)(2)	08/27/2036	Common Stock	23,855	$0	23,855	D

Explanation of Responses:

1. The options have an exercise price of $60.00 per share and the shares subject to the options become exercisable in three equal annual installments on each of August 27, 2027, August 27, 2028 and August 27, 2029, subject to the Reporting Person's continued service through each applicable vesting date.

2. The options were granted outside of the Issuer's 2016 Equity Incentive Plan as an employment inducement award under New York Stock Exchange Listing Rule 303A.08 and as a material inducement to the Reporting Person entering into employment with the Issuer. The awards were approved by the Compensation Committee of the Board of Directors, consisting solely of independent directors, in reliance on the employment inducement exemption under NYSE Listing Rule 303A.08.

Remarks:

The Reporting Person was inadvertently designated as a director in a previously filed Form 4. The Reporting Person was not a director of the Issuer at the time of such filing. This Form 4 reflects the Reporting Person's correct officer status.

	/s/ Jamie Barber, as Attorney-in-Fact	08/31/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)